IMMUNOBRAIN

From the scientists who pioneered the discovery of the immune system’s role in brain protection and repair

Clinical-stage biopharmaceutical company

Advancing first-of-its-kind approach to harness the peripheral immune system to combat neurodegeneration, and extend brain health and longevity

0

Years of dogma-breaking research

0+

Peer-reviewedpublications

0

Grantedpatents

Interconnected blue neural filaments

Peripheral immune system and brain

The peripheral immune system plays a critical role in brain protection and repair.

Growing Challenge

NEARLY 10 MILLION

new cases of dementia every year worldwide

As the world's population ages, Alzheimer's disease and other dementias are becoming increasingly prevalent.

Our Mission

Immunobrain is on a mission to bring a differentiated approach, driving neuroprotective effect, with convenient quarterly dosing and the potential to significantly slow - or prevent - cognitive decline.

Encouraging data from the completed Phase 1b study support this approach.

See our publications

For more information about ongoing clinical studies

Explore clinical studies

Latest News

July 28, 2026 · NeurologyLive

IBC-Ab002 Shows Favorable Safety Profile, Exploratory Biomarker Signals in Alzheimer Disease Trial

July 14, 2026 · PR Newswire

Immunobrain Announces Nature Medicine Publication and Late-Breaking AAIC 2026 Presentation for IBC-Ab002 in Early Alzheimer’s Disease

March 12, 2026 · PR Newswire

Immunobrain to Present Topline Phase 1b Clinical Data for Immune Checkpoint Treatment in Alzheimer’s Disease at AD/PD™ 2026